PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+57.27%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.67B
AUM Growth
+$1.67B
(+39%)
Cap. Flow
-$70.6M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
75.81%
Holding
42
New
5
Increased
4
Reduced
20
Closed
1
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$26.6M |
| 2 |
Gossamer Bio
GOSS
|
$2.66M |
| 3 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$2.55M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$2.02M |
| 5 |
Aprea Therapeutics
APRE
|
$1.83M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$28.1M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$22.2M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$17M |
| 4 |
United Therapeutics
UTHR
|
$13.3M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$6.96M |
Sector Composition
| 1 | Healthcare | 83.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $184M | 11.03% | 5,182,983 -107,763 | -2% | -$3.82M |
|
|
2
STAAR Surgical
STAA
$1.36B
| $174M | 10.42% | 2,821,154 -457,369 | -14% | -$28.1M |
|
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $173M | 10.41% | 1,405,950 -138,213 | -9% | -$17M |
|
4
Insmed
INSM
$28.8B
| $165M | 9.93% | 6,002,289 -53,334 | -0.9% | -$1.47M |
|
|
ABMD
5
DELISTED
Abiomed Inc
ABMD
| $119M | 7.14% | 492,333 -10,412 | -2% | -$2.52M |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $111M | 6.64% | 7,334,714 -112,904 | -2% | -$1.7M |
|
|
7
United Therapeutics
UTHR
$13.8B
| $92.7M | 5.57% | 766,406 -110,169 | -13% | -$13.3M |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $88.6M | 5.32% | 5,513,676 -38,127 | -0.7% | -$612K |
|
9
Karyopharm Therapeutics
KPTI
$61.7M
| $79.9M | 4.8% | 4,219,452 -80,449 | -2% | -$1.52M |
|
10
Acadia Pharmaceuticals
ACAD
$4.38B
| $75.9M | 4.55% | 1,564,900 -66,624 | -4% | -$3.23M |
|
|
AIMT
11
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $55.4M | 3.33% | 3,318,212 +22,500 | +0.7% | +$376K |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $49.9M | 3% | 444,629 -197,862 | -31% | -$22.2M |
|
|
MNTA
13
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $49.2M | 2.96% | 1,479,524 -48,432 | -3% | -$1.61M |
|
14
Vanda Pharmaceuticals
VNDA
$279M
| $47.1M | 2.83% | 4,116,548 -18,298 | -0.4% | -$209K |
|
|
RVNC
15
DELISTED
Revance Therapeutics, Inc.
RVNC
| $41.6M | 2.5% | 1,704,372 +1,088,667 | +177% | +$26.6M |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $29.4M | 1.77% | 4,361,411 -274,378 | -6% | -$1.85M |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $23.9M | 1.44% | 575,200 -11,474 | -2% | -$477K |
|
|
AMAG
18
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $22.6M | 1.36% | 2,959,587 -43,161 | -1% | -$330K |
|
19
Align Technology
ALGN
$10.3B
| $18.5M | 1.11% | 67,505 -8,700 | -11% | -$2.39M |
|
20
Puma Biotechnology
PBYI
$254M
| $14M | 0.84% | 1,343,897 -52,266 | -4% | -$545K |
|
|
DRNA
21
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.43M | 0.51% | 331,813 | – | – |
|
22
Prothena Corp
PRTA
$441M
| $8.07M | 0.48% | 771,065 -4,231 | -0.5% | -$44.3K |
|
23
Rigel Pharmaceuticals
RIGL
$697M
| $6.48M | 0.39% | 3,542,551 | – | – |
|
|
KLDO
24
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $5.84M | 0.35% | 786,400 -1,599 | -0.2% | -$11.9K |
|
25
Cytokinetics
CYTK
$4.23B
| $2.92M | 0.18% | 123,686 | – | – |
|